<DOC>
	<DOCNO>NCT01851005</DOCNO>
	<brief_summary>Emergence elderly patient anesthesia may face cognitive dysfunction agitation delirium . There report use dexmedetomidine adjuvant general anesthesia decrease emergence-agitation child dexmedetomidine may use treat delirium . Thus , think dexmedetomidine adjuvant agent may help smooth emergence anesthesia elderly . The aim study investigate recovery characteristic ( time recovery consciousness ( ROC ) recovery , bispectral index ( BIS ) value ROC orientation , Ricker sedation-agitated scale postanesthetic care unit ) safety ( vital sign administration dexmedetomidine ) dexmedetomidine elderly patient undergo elective surgery .</brief_summary>
	<brief_title>Effect Dexmedetomidine Recovery Profiles Elderly Patients</brief_title>
	<detailed_description>Purpose : The aim study investigate recovery characteristic ( time recovery consciousness ( ROC ) recovery , bispectral index ( BIS ) value ROC orientation , Ricker sedation-agitated scale postanesthetic care unit ) safety ( vital sign administration dexmedetomidine ) dexmedetomidine elderly patient undergo elective surgery . Hypothesis : Dexmedetomidine adjuvant agent may help smooth emergence anesthesia elderly . Objectives : Patients schedule undergo elective surgery , American society anesthesiologist class ( ASA ) I-II , age 65 year , randomly allocate six group . - Group 1 : general anesthesia sevoflurane ( placebo : normal saline ) - Group 2 : general anesthesia propofol remifentanil ( total intravenous anesthesia ) ( placebo : normal saline ) - Group 3 : general anesthesia sevoflurane adjuvant dexmedetomidine - Group 4 : general anesthesia propofol remifentanil ( total intravenous anesthesia ) , adjuvant dexmedetomidine Research Method : Once operate room , patient monitor electrocardiography , non invasive blood pressure , pulse oximetry ( Datex-Ohmeda S/5 , Planar Systems , Inc. , Beaverton , OR , USA ) BIS ( Aspect 2000 , Aspect Medical Systems , Inc. , Newton , MA , USA ) . In group 1 group 3 , anesthesia induce propofol ( 2mg/kg ) follow administer rocuronium 0.6 mg/kg . After tracheal intubation , lungs patient ventilate oxygen air ( 1:2 ) , ventilation rate adjust maintain end-tidal carbon dioxide partial pressure 35 45 mmHg . The concentration sevoflurane adjust maintain BIS score 40 45 . In group 2 group 4 , anesthesia induce maintain total intravenous anesthesia use propofol remifentanil . Effective site concentration propofol remifentanil adjust maintain BIS 40 45 maintain change vital sign 20 % baseline value . In group 3 group 4 , dexmedetomidine administer ( 0.4 ug/kg/hr ) surgery . Instead , group 1 group 2 , normal saline administer rate placebo . The concentration sevoflurane measure continuously use infrared anesthetic gas analyzer ( Datex-Ohmeda S/5 , Planar Systems , Inc. , Beaverton , OR , USA ) effect site concentration propofol remifentanil also measure target control infuser ( Orchestra® Base Primea , Fresenius-Vial , France ) surgery . After end surgery , anesthetic dexmedetomidine discontinue time recovery BIS score 60 , 70 , 80 measure . Patients ask open eye time eye opening measure . After eye opening , reversal agent administer patient transfer postanesthetic care unit ( PACU ) . After arrival PACU , blood pressure , heart rate , Ricker sedation-agitated scale measure every 5 minute . When Ricker sedation-agitated scale become 4 , patient transfer ward , time stay postanesthetic care unit measure . The incidence nausea , vomit , hypotension , hypertension , bradycardia , tachycardia measure surgery stay postanesthetic care unit . All participant follow duration surgery postanesthetic care unit stay , expect average 1 day . Statistical Analysis : All data express mean ± standard deviation . Recovery profile ( time recovery consciousness ( ROC ) recovery , BIS value ROC orientation , Ricker sedation-agitated scale postanesthetic care unit ) analyze paired t-test . And incidence nausea/vomiting , hypotension , hypertension , bradycardia , tachycardia analyze Chi-square test .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<criteria>ASA III Age &gt; 65 Elective surgery Patients severe heart disease New York Heart Association class &gt; III Patients severe arrhythmia Patients uncontrolled hypertension hypotension Patients hemodynamic unstably Patients hypersensitivity drug Patients cognitive deficiency , dementia , delirium Patients hepatic renal compromise Patients infective disease</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Anesthesia</keyword>
	<keyword>Recovery profile</keyword>
</DOC>